Saudi Society of Maternal-Fetal Medicine guidance on pregnancy and coronavirus disease 2019

References

1. ↵
   1. Zhu H,
   2. Wang L,
   3. Fang C,
   4. Peng S,
   5. Zhang L,
   6. Chang G,
   7. et al.

   (2020) Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr 9:51–60.

   OpenUrlCrossRefPubMed
2. ↵
   1. World Health Organization

   Coronavirus disease 2019 (COVID-2019) pandemic, Available from URLhttps://www.who.int/emergencies/diseases/novel-coronavirus-2019. [Updated 2020. Assessed 6 June 2020].
3. ↵
   1. World Health Organization (WHO)

   Naming the coronavirus disease (COVID-19) and the virus that causes it, Available from URL:https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it. [Updated 2020. Assessed 2020 June 6].
4. ↵
   1. World Health Organization

   Rolling updates on coronavirus disease (COVID-19), Available from URL:https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen. [Updated 2020 June 29. Assessed 2020 June 6].
5. ↵
   1. Yu N,
   2. Wei L,
   3. Kang Q,
   4. Xiong Z,
   5. Wang S,
   6. Lin X,
   7. et al.

   (2020) Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China:a retrospective, single-centre, descriptive study. Lancet Infect Dis 20:559–564.

   OpenUrlPubMed
6. ↵
   1. Hindson J

   (2020) COVID-19:faecal-oral transmission? Nat Rev Gastroenterol Hepatol 17:259–259.

   OpenUrlPubMed
7. ↵
   1. Xu Y,
   2. Li X,
   3. Zhu B,
   4. Liang H,
   5. Fang C,
   6. Gong Y,
   7. et al.

   (2020) Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med 26:502–505.

   OpenUrlCrossRefPubMed
8. ↵
   1. Schwartz DA,
   2. Graham AL

   (2020) Potential maternal and infant outcomes from coronavirus 2019-nCoV (SARS-CoV-2) infecting pregnant women:lessons from SARS, MERS, and other human coronavirus infections. Viruses 12:194.

   OpenUrlCrossRefPubMed
9. ↵
   1. Society for Maternal-Fetal Medicine (SMFM),
   2. Sarah Dotters-Katz MD, MMHPE.,
   3. Brenna L. Hughes MD, MSc.

   On March 11, 2020, Coronavirus (COVID-19) and pregnancy:what maternal-fetal medicine subspecialists need to know, Available from URL:https://s3.amazonaws.com/cdn.smfm.org/media/2262/COVID19_PDF.pdf/. [Updated 2020. Assessed 2020 March 11].
10. ↵
    1. Power J

    Coronavirus:South Korea's aggressive testing gives clues to true fatality rate. South China Morning Post, Available from URL:https://www.scmp.com/week-asia/health-environment/article/3065187/coronavirus-south-koreas-aggressive-testing-gives/. Updated 2020. Assessed 2020 March 20.
11. ↵
    1. Wang D,
    2. Hu B,
    3. Hu C,
    4. Zhu F,
    5. Liu X,
    6. Zhang J,
    7. et al.

    (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323:1061–1069.

    OpenUrlCrossRefPubMed
12. ↵
    1. Zaigham M,
    2. Andersson O

    (2020) Maternal and perinatal outcomes with COVID?19:a systematic review of 108 pregnancies. Acta Obstet Gynecol Scand 99:823–829.

    OpenUrlCrossRefPubMed
13. ↵
    1. Chen H,
    2. Guo J,
    3. Wang C,
    4. Luo F,
    5. Yu X,
    6. Zhang W,
    7. et al.

    (2020) Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women:a retrospective review of medical records. Lancet 395:809–815.

    OpenUrlCrossRefPubMed
14. ↵
    1. Wong SF,
    2. Chow KM,
    3. Leung TN,
    4. Ng WF,
    5. Ng TK,
    6. Shek CC,
    7. et al.

    (2004) Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol 191:292–297.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    1. Shek CC,
    2. Ng PC,
    3. Fung GP,
    4. Cheng FW,
    5. Chan PK,
    6. Peiris MJ,
    7. et al.

    (2003) Infants born to mothers with severe acute respiratory syndrome. Pediatrics 112:e254.

    OpenUrlAbstract/FREE Full Text
16. ↵
    1. Schwartz DA

    (2020) An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-2 fetal transmission of SARS-CoV-2:maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med 144:799–805.

    OpenUrlPubMed
17. ↵
    1. Dong L,
    2. Tian J,
    3. He S,
    4. Zhu C,
    5. Wang J,
    6. Liu C,
    7. et al.

    (2020) Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn. JAMA 323:1846–1848.

    OpenUrlPubMed
18. ↵
    1. Zeng L,
    2. Xia S,
    3. Yuan W,
    4. Yan K,
    5. Xiao F,
    6. Shao J,
    7. et al.

    (2020) Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatr 174:722–725.

    OpenUrl
19. ↵
    1. Woodward A

    A pregnant mother infected with the coronavirus gave birth, and her baby tested positive 30 hours later. Business Insider, Available from URL:https://www.businessinsider.com/wuhan-coronavirus-in-infant-born-from-infected-mother-2020-2. Updated 2020 February 5. Accessed 2020 March 30.
20. ↵
    1. Murphy S

    Newborn baby tests positive for coronavirus in London. The Guardian, Available online:https://www.theguardian.com/world/2020/mar/14/newborn-baby-tests-positive-for-coronavirus-in-london. [Updated 2020 March 14. Accessed 2020 March 30].
21. ↵
    1. Anderson RM,
    2. Heesterbeek H,
    3. Klinkenberg D,
    4. Hollingsworth TD

    (2020) How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet 395:931–934.

    OpenUrlCrossRefPubMed
22. ↵
    1. Sonek J,
    2. Kagan K,
    3. Nicolaides K

    (2016) Inverted pyramid of care. Clin Lab Med 36:305–317.

    OpenUrl
23. ↵
    1. Alaboudi A,
    2. Atkins A,
    3. Sharp B,
    4. Balkhair A,
    5. Alzahrani M,
    6. Sunbul T

    (2016) Barriers and challenges in adopting Saudi telemedicine network:the perceptions of decision makers of healthcare facilities in Saudi Arabia. J Infect Public Health 9:725–733.

    OpenUrl
24. ↵
    RCOG Coronavirus (COVID-19) infection in pregnancy information for healthcare professionals Version 5, Available from URL:https://www.rcog.org.uk/coronavirus-pregnancy/. Accessed on March 28, 2020.
25. ↵
    1. Weqaya

    Saudi Center for Disease Prevention and Control. Coronavirus Disease 19 (COVID-19) Guidelines, Available from URL:https://www.moh.gov.sa/Ministry/MediaCenter/Publications/Documents/Coronavirus-Disease-2019-Guidelines-v1.2.pdf/. Updated 2020 May. Accessed on 2020 March 20.
26. ↵
    1. Yao X,
    2. Ye F,
    3. Zhang M,
    4. Cui C,
    5. Huang B,
    6. Niu P,
    7. et al.

    (2020) In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis, ciaa237.
27. ↵
    1. Gao J,
    2. Tian Z,
    3. Yang X

    (2020) Breakthrough:chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 14:72–73.

    OpenUrlCrossRefPubMed
28. ↵
    1. Colson P,
    2. Rolain JM,
    3. Lagier JC,
    4. Brouqui P,
    5. Raoult D

    (2020) Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents 55:105932.

    OpenUrlPubMed
29. ↵
    1. Cortegiani A,
    2. Ingoglia G,
    3. Ippolito M,
    4. Giarratano A,
    5. Einav S

    (2020) A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care 57:279–283.

    OpenUrlPubMed
30. ↵
    1. Gautret P,
    2. Lagier J-C,
    3. Parola P,
    4. Hoang VT,
    5. Meddeb L,
    6. Mailhe M,
    7. et al.

    (2020) Hydroxychloroquine and azithromycin as a treatment of COVID?19:results of an open?label non?randomized clinical trial. Int J Antimicrob Agents, 105949.
31. ↵
    Centers for Disease Control or Prevention. Therapeutic options for patients with COVID-19, Available from:https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html. [Updated 2020 June 16. 2020 Accessed March 22].
32. ↵
    National Institutes of Health. COVID-19 treatment guidelines. Chloroquine or Hydroxychloroquin, Available from URL:https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/chloroquine-or-hydroxychloroquine/. Updated 2020 June 16. Accessed 2020 June 3.
33. ↵
    National Institutes of Health. COVID-19 treatment guidelines. Hydroxychloroquine plus Azithromycin, Available from URL:https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/hydroxychloroquine-plus-azithromycin/. Updated 2020 May 12. Accessed 2020 June 3.
34. ↵
    1. Ford N,
    2. Vitoria M,
    3. Rangaraj A,
    4. Norris SL,
    5. Calmy A,
    6. Doherty M

    (2020) Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS, or COVID?19:initial assessment. J Int AIDS Soc 23:e25489.

    OpenUrlCrossRefPubMed
35. ↵
    RECOVERY. No clinical benefit from use of lopinavir-ritonavir in hospitalized COVID-19 patients studied in RECOVERY. Recovery Trial, Available from URL:https://www.recoverytrial.net/news/no-clinical-benefit-from-use-of-lopinavir-ritonavir-in-hospitalised-covid-19-patients-studied-in-recovery. Updated 2020. Accessed 2020 June 29.
36. ↵
    1. Sheahan TP,
    2. Sims AC,
    3. Graham RL,
    4. Menachery VD,
    5. Gralinski LE,
    6. Case JB,
    7. et al.

    (2017) Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med 9:eaal3653.

    OpenUrlAbstract/FREE Full Text
37. ↵
    National Institutes of Health. What's New in the Guidelines, Available from URL:https://www.covid19treatmentguidelines.nih.gov/whats-new/. [Updated 2020 June 25. Accessed 2020 June 3].
38. ↵
    1. Fedson DS,
    2. Opal SM,
    3. Rordam OM

    (2020) Hiding in plain sight:an approach to treating patient with severe COVID-19 infection. mBio 11:e00398–20.

    OpenUrl
39. ↵
    1. National Institutes of Health

    Convalescent Plasma and Immune Globulins, Available from URL:https://www.covid19treatmentguidelines.nih.gov/immune-based-therapy/convalescent-plasma-and-immune-globulins/. [Updated 2020 May 12. Accessed 2020 June 3].
40. ↵
    1. Russell CD,
    2. Millar JE,
    3. Baillie JK

    (2020) Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 395:473.

    OpenUrlCrossRefPubMed
41. ↵
    1. Horby P,
    2. Lim WS,
    3. Emberson J,
    4. Mafham M,
    5. Bell J,
    6. Linsell L,
    7. et al.

    (2020) Effect of Dexamethasone in Hospitalized Patients with COVID-19:Preliminary Report. medRxiv 2020:1–24.

    OpenUrl
42. ↵
    Ministry of Health. Saudi MoH Protocol for Patients Suspected of/Confirmed with COVID-19. Supportive care and antiviral treatment of suspected or confirmed COVID-19 infection, Available from URL:https://www.moh.gov.sa/Ministry/MediaCenter/Publications/Documents/MOH-therapeutic-protocol-for-COVID-19.pdf. Updated 2020 June 17. Accessed 2020 June 19.
43. ↵
    1. Day M

    (2020) Covid-19:ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ 368:m1086.

    OpenUrlFREE Full Text
44. ↵
    European Medicines Agency. EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19, Available from URL:https://www.ema.europa.eu/en/news/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19. Updated 2020 March 18.Accessed 2020 June 29.
45. ↵
    Science Alert. Updated:WHO now doesn't recommend avoiding ibuprofen for COVID-19 symptoms, Available from URL:https://www.sciencealert.com/who-recommends-to-avoid-taking-ibuprofen-for-covid-19-symptoms. [Updated 2020 March 17. Accessed 2020 March 19.
46. ↵
    1. Zhou F,
    2. Yu T,
    3. Du R,
    4. Fan G,
    5. Liu Y,
    6. Liu Z,
    7. et al.

    (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China:a retrospective study. Lancet 395:1054–1062.

    OpenUrlCrossRefPubMed
47. ↵
    1. Rebarber A,
    2. Ferrara LA,
    3. Hanley ML,
    4. Istwan NB,
    5. Rhea DJ,
    6. Stanziano GJ,
    7. et al.

    (2007) Increased recurrence of preterm delivery with early cessation of 17-alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol 196:224.e1–224.e4.

    OpenUrlPubMed
48. ↵
    1. National Institutes of Health

    Thromboprophylaxis and anticoagulation in COVID?19 infection, Available from URL:https://www.wsh.nhs.uk/covid-staff-zone/Guidelines-SOPs-clinical-info/Docs/Clinical-guideline/CG10393-COVID-Thromboprophylaxis-and-Anticoagulation-in-COVID-19-infections.pdf. [Updated 2020 May. Accessed 2020 June 29].
49. ↵
    1. American College of Obstetricians and Gynecologists

    COVID-19 FAQs for Obstetrician-Gynecologists, Obstetrics, Available form URL:https://www.acog.org/clinical-information/physician-faqs/covid-19-faqs-for-ob-gyns-obstetrics. Updated 2020. Accessed 2020 March 25.
50. ↵
    The American Academy of Dermatology. Article Title, Available from URL:https://assets.ctfassets.net/1ny4yoiyrqia/PicgNuD0IpYd9MSOwab47/023ce3cf6eb82cb304b4ad4a8ef50d56/Biologics_and_COVID-19.pdf. Updated 2020. Accessed 2020 March 18.
51. American College of Rheumatology, Available from URL:https://www.rheumatology.org/announcements. Updated 2020 June 14 Accessed 2020 March 18].
52. ↵
    1. Joint GI

    Society message:COVID-19 clinical insights for our community of gastroenterologists and gastroenterology care providers, Available from URL:https://www.gastro.org/press-release/joint-gi-society-message-covid-19-clinical-insights-for-our-community-of-gastroenterologists-and-gastroenterology-care-providers. [Updated 2020 March 16 Accessed on March 18, 2020].
53. ↵
    1. Moore SA,
    2. Dietl CA,
    3. Coleman DM

    (2016) Extracorporeal life support during pregnancy. J Thorac Cardiovasc Surg 151:1154–1160.

    OpenUrlCrossRefPubMed
54. ↵
    1. Chen ZL,
    2. Zhang WJ,
    3. Lu Y,
    4. Guo C,
    5. Guo ZM,
    6. Liao CH,
    7. et al.

    (2020) From SARS-CoV to 2019-nCoV outbreak:similarities in the early epidemics and prediction of future trends. Chin Med J (Engl) 133:1112–1114.

    OpenUrl
55. ↵
    1. Palatnik A,
    2. McIntosh JJ

    (2020) Protecting labor and delivery personnel from COVID-19 during the second stage of labor. Am J Perinatol 37:854–856.

    OpenUrl
56. ↵
    SOGC COVID-19 Infectious Disease Committee Statement (March 13, 2020) Coronavirus (COVID-19) Infection in Pregnancy, Information for healthcare professionals, version 5, Available from URL:https://sogc.org/en/-COVID-19/en/content/COVID-19/COVID-19.aspx. Updated 2020 May 14 Accessed 2020 June 29.
57. ↵
    1. Alyamani O,
    2. Abushoshah I,
    3. Tawfeeq N,
    4. Al Dammas F,
    5. Algurashi F

    (2020) Considerations and recommendations for obstetric anesthesia care during COVID-19 pandemic - Saudi anesthesia society guidelines. Saudi J Anaesth 14:359–364.

    OpenUrl
58. ↵
    1. Amatullah AF

    (2018) Using interprofessional simulation-based training to improve management of obstetric emergencies:a systematic review. Clin Simul Nurs 14:45–53.

    OpenUrl
59. ↵
    1. Fang L,
    2. Karakiulakis G,
    3. Roth M

    (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med e21, 8.
60. ↵
    Centers for Disease Control and Prevention. Interim considerations for infection prevention and control of coronavirus disease 2019 (COVID-19) in inpatient obstetric healthcare settings, Available from URL:https://www.cdc.gov/coronavirus/2019-ncov/hcp/inpatient-obstetric-healthcare-guidance.html. Updated 20 May 2020. Viewed 29 March 2020.
61. ↵
    1. Wall-Wieler E,
    2. Carmichael SL,
    3. Urquia ML,
    4. Liu C,
    5. Hjern A

    (2019) Severe maternal morbidity and postpartum mental health-related outcomes in Sweden:a population-based matched-cohort study. Arch Womens Ment Health 22:519–526.

    OpenUrl
62. ↵
    1. Wang L,
    2. Shi Y,
    3. Xiao T,
    4. FU J,
    5. Feng X,
    6. Mu D,
    7. et al.

    (2020) Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection. Ann Transl Med 8:47.

    OpenUrl
63. ↵
    Saudi MOH COVID-19 in Pregnancy Rapid Response Guidelines Version 1.1, Available form URL:https://www.moh.gov.sa/Ministry/MediaCenter/Publications/Documents/COVID-19-IN-PREGNANCY-MOH-Protocol.pdf/. Updated 2020. Accessed 2020 March 31].
64. ↵
    1. Qia J

    (2020) What are the risks of COVID-19 infection in pregnant women? Lancet 395:760–762.

    OpenUrlPubMed
65. ↵
    1. Liang H,
    2. Acharya G

    (2020) Novel corona virus disease (COVID?19) in pregnancy:what clinical recommendations to follow? Acta Obstet Gynecol Scand 99:439–442.

    OpenUrlPubMed
66. ↵
    The American College of Obstetricians and Gynecologist. Clinical Guidance-Practice Advisory-Novel Coronavirus 2019 (COVID-19), Available from URL:https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/03/novel-coronavirus-2019. Updated 2020 July 1. Accessed 2020 March 28.
67. ↵
    Centers for Disease Control and Prevention. Discontinuation of home isolation for persons with COVID-19 (Interim Guidance), Available from URL:https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-in-home-patients.html. [Udpated 2020 May 29. Accessed on March 17, 2020].
68. ↵
    1. Saudi MOH

    Guideline for Neonate Born to Mothers with Suspected or Confirmed COVID-19 Infection, Available from URL:https://www.moh.gov.sa/Ministry/MediaCenter/Publications/Documents/Guideline-for-Neonate-born-to-COVID-19-Mother.pdf. [Updated 2020 April 12 Accessed 2020 June 4].
69. ↵
    FAQs:Management of Infants Born to Mothers with Suspected or Confirmed COVID-19, https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/faqs-management-of-infants-born-to-covid-19-mothers/. [Updated 2020 Accessed on 2020 June 4].